APRE
Aprea Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.74
-0.02 ▼ -3.79%
🌙 3월 13일 4:24 PM ET (한국 3/14 05:24)
$0.72
-0.01 ▼ -1.86%
| Index | - | P/E | - | EPS (ttm) | -2.14 | Insider Own | 20.46% | Shs Outstand | 0.01B | Perf Week | -18.24% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 40.87% | Insider Trans | 2.64% | Shs Float | 0.01B | Perf Month | 19.99% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -0.39 | Inst Own | 14.81% | Short Float | 2.7% | Perf Quarter | -19.32% |
| Income | -0.01B | P/S | 17.2 | EPS this Y | 15.32% | Inst Trans | 7.76% | Short Ratio | 0.11 | Perf Half Y | -53.12% |
| Sales | 0.00B | P/B | 0.4 | EPS next 5Y | 29.22% | ROA | -63.27% | Short Interest | 0.25M | Perf YTD | -13.72% |
| Book/sh | 1.83 | P/C | 0.61 | EPS past 3/5Y | 59.3% 52.12% | ROE | -74.72% | 52W High | -72.64% ($2.69) | Perf Year | -69.01% |
| Cash/sh | 1.2 | P/FCF | - | Sales past 3/5Y | - | ROIC | -112.01% | 52W Low | 34.31% ($0.55) | Perf 3Y | -85.58% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 23.87% | Gross Margin | 95.55% | Volatility(W/M) | 7.08% 11.57% | Perf 5Y | -99.38% |
| Dividend TTM | - | EV/Sales | -9.31 | Sales Y/Y TTM | -62.75% | Oper. Margin | -2829.92% | ATR (14) | 0.09 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.2 | EPS Q/Q | 26.78% | Profit Margin | -2670.56% | RSI (14) | 42.65 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.2 | Sales Q/Q | -99.48% | SMA20 | -9.3% ($0.82) | Beta | 1.49 | Target Price | $5.33 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -8.25% ($0.81) | Rel Volume | 0.06 | Prev Close | $0.76 |
| Employees | 8 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -38.24% - | SMA200 | -44.21% ($1.33) | Avg Volume(3M) | 2.17M | Price | $0.74 |
| IPO | 2019/10/3 | Option/Short | No/Yes | Trades | 188 | Volume | 122,726 | Change | -3.79% |
뉴스 로딩 중...